← Eichor
Study identifier: NCT06758544 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

A Single-arm, Open-label Clinical Study to Evaluate the Efficacy and Safety of VRT106 in Combination With Chemotherapy for Resectable Pancreatic Cancer

Condition: Pancreatic Cancer  ·  Sponsor: Guangdong Provincial People's Hospital

PhasePhase 1/Phase 2
Planned participants18
Who can joinAll sexes, 18 Years to 75 Years
Healthy volunteersNo

About this study

This is a single-center, single-arm, open investigator-initiated clinical study to evaluate the efficacy and safety of VRT106 in combination with chemotherapy in the treatment of resectable pancreatic cancer.

This description comes directly from the study's public registry record.

Talk to the study team

Chen RF Prof.  ·  020-83525210  ·  chenrf63@163.com

Always discuss trial participation with your own doctor first.

Locations (1)

Guangdong Provincial People's HospitalGuangzhou, Guangdong, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06758544